Affiliation:
1. Division of Rheumatology, Department of Internal Medicine, University Hospital,1 and
2. Medical Biochemistry Department, Geneva Medical School,2 1211 Geneva 14, Switzerland
Abstract
ABSTRACT
Different immunoassays using recombinant antigens or synthetic peptides were evaluated for the serodiagnosis of
Chlamydia trachomatis
infections. Antigens used included cysteine-rich outer membrane protein 2 (OMP2), heat shock protein 60, the polypeptide encoded by open reading frame 3 of the plasmid (pgp3), synthetic peptides derived from species-specific epitopes in variable domain IV of the major OMP (MOMP) (Labsystems, Helsinki, Finland), and a fragment of the total lipopolysaccharide (Medac, Hamburg, Germany). Because cross-reactions between chlamydial species have been reported,
Chlamydia pneumoniae
-specific antibodies were also determined by immunoassays (Labsystems). Responses obtained with serum samples from patients with well-defined diseases (i.e., urethral or endocervical samples from which
C. trachomatis
DNA was amplified) were compared to those obtained with samples from healthy blood donors. The best sensitivity (79%) associated with the best specificity (82%) was obtained when immunoglobulin G (IgG) responses to both MOMP and pgp3 were considered. The highest sensitivity (89%) was obtained with anti-OMP2 IgG, but the lowest specificity (57%) was obtained with this antibody, due to probable cross-reactivity with
C. pneumoniae
OMP2.
Publisher
American Society for Microbiology
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献